STOCK TITAN

YBCN Financials

YBCN
Source SEC Filings (10-K/10-Q) Updated Sep 30, 2025 Currency USD FYE December

This page shows YBCN (YBCN) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Earnings Quality Low Quality
0.00x

For every $1 of reported earnings, YBCN generates $0.00 in operating cash flow ($0 OCF vs -$40K net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$0

YBCN generated $0 in revenue in fiscal year 2024.

EBITDA
N/A
Net Income
-$40K
YoY+35.8%

YBCN reported -$40K in net income in fiscal year 2024. This represents an increase of 35.8% from the prior year.

EPS (Diluted)
$0.00

YBCN earned $0.00 per diluted share (EPS) in fiscal year 2024.

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$0

YBCN held $0 in cash against $0 in long-term debt as of fiscal year 2024.

Dividends Per Share
N/A
Shares Outstanding
189M
YoY+0.0%
5Y CAGR+12.4%

YBCN had 189M shares outstanding in fiscal year 2024. This represents an increase of 0.0% from the prior year.

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
Return on Equity
N/A

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
N/A

YBCN Income Statement

Metric Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23
Revenue $0 $0 $0 N/A $0 $0 $0 N/A
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses N/A N/A N/A N/A N/A N/A N/A N/A
Operating Income -$7K+25.6% -$9K+10.1% -$10K N/A -$8K+18.6% -$9K+47.3% -$18K N/A
Interest Expense $0 $0 $0 N/A $0 $0 $0 N/A
Income Tax $0 $0 $0 N/A $0 $0 $0 N/A
Net Income -$7K+25.6% -$9K+10.1% -$10K N/A -$8K+18.6% -$9K+47.3% -$18K N/A
EPS (Diluted) $0.00 $0.00 $0.00 N/A $0.00 $0.00 $0.00 N/A

YBCN Balance Sheet

Metric Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23
Total Assets $0 $0 $0 $0 $0 $0 $0 $0
Current Assets $0 $0 $0 $0 $0 $0 $0 $0
Cash & Equivalents $0 $0 $0 $0 $0 $0 $0 $0
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $173K+4.2% $166K+6.0% $157K+7.1% $146K+3.5% $142K+5.7% $134K+7.6% $124K+16.7% $107K
Current Liabilities $173K+4.2% $166K+6.0% $157K+7.1% $146K+3.5% $142K+5.7% $134K+7.6% $124K+16.7% $107K
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity -$173K-4.2% -$166K-6.0% -$157K-7.1% -$146K-3.5% -$142K-5.7% -$134K-7.6% -$124K-16.7% -$107K
Retained Earnings -$3.7M-0.2% -$3.7M-0.3% -$3.7M-0.3% -$3.7M-0.1% -$3.7M-0.2% -$3.7M-0.3% -$3.7M-0.5% -$3.7M

YBCN Cash Flow Statement

Metric Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23
Operating Cash Flow -$31K $0 $0-100.0% $28K+200.0% -$28K $0 $0 $0
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Financing Cash Flow $31K N/A N/A N/A $28K N/A N/A $0
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

YBCN Financial Ratios

Metric Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin N/A N/A N/A N/A N/A N/A N/A N/A
Return on Equity N/A N/A N/A N/A N/A N/A N/A N/A
Return on Assets N/A N/A N/A N/A N/A N/A N/A N/A
Current Ratio 0.000.0 0.000.0 0.000.0 0.000.0 0.000.0 0.000.0 0.000.0 0.00
Debt-to-Equity -1.000.0 -1.000.0 -1.000.0 -1.000.0 -1.000.0 -1.000.0 -1.000.0 -1.00
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Note: Shareholder equity is negative (-$146K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.00), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

YBCN (YBCN) reported $0 in total revenue for fiscal year 2024. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

No, YBCN (YBCN) reported a net income of -$40K in fiscal year 2024.

YBCN (YBCN) reported diluted earnings per share of $0.00 for fiscal year 2024. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

YBCN (YBCN) generated $0 in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

YBCN (YBCN) had $0 in total assets as of fiscal year 2024, including both current and long-term assets.

YBCN (YBCN) had 189M shares outstanding as of fiscal year 2024.

YBCN (YBCN) had a current ratio of 0.00 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.

YBCN (YBCN) had a debt-to-equity ratio of -1.00 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

YBCN (YBCN) has negative shareholder equity of -$146K as of fiscal year 2024, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

YBCN (YBCN) has an earnings quality ratio of 0.00x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top